Harder Harder A A MEK inhibitors—novel targeted therapies of neurofibromatosis associated benign and malignant lesions MEK inhibitors—novel targeted therapies of neurofibromatosis associated benign and malignant lesions Biomark Res Biomark Res 2021 2021 10.1186/S40364-021-00281-0 10.1186/S40364-021-00281-0 supplied-pmid 33863389? Here, MAP2K7 is linked to neurofibromatosis.